1 Undersecretary of Promotion and Environmental Regulation, Secretariat of Environment and Natural Resources, Mexico.
2 Department of Economics, Autonomous Metropolitan University, Mexico.
3 Department of Electrical Engineering, Autonomous Metropolitan University, Mexico.
4 Department of Health Sciences, Autonomous Metropolitan University, Mexico.
Research Article
GSC Biological and Pharmaceutical Sciences, 2022, 20(03), 167–174.
Article DOI: 10.30574/gscbps.2022.20.3.0358
Received on 07 August 2022; revised on 12 September 2022; accepted on 14 September 2022
COVID-19 outbreak exposed the governance and governability limitations of world health care systems, and México was no exception. With data from the Mexican Ministry of Health, two Gompertz models were estimated with a time horizon of the first three months of the pandemic. Factors such as chronic diseases, age groups, and sex were related. The probability of dying increased with age >51 years and in men. Comorbidities increased the probability of death: Diabetes at 70.1%, renal failure at 50.8%, and obesity at 42.7%. Compared to other countries, México was unable during the initial stage of the Covid-19 outbreak to establish a coherent policy appropriate to the epidemiological emergency.
COVID-19; Governance; Comorbidities; Gompertz model; Policy; Technology
Preview Article PDF
Francisco Aguilar-Bustamante, Raúl Enrique Molina-Salazar, José Antonio Amozurrutia-Jiménez, Fabiola Margarita Martínez-Licona and José Federico Rivas-Vilchis. Immediate effect of the COVID-19 pandemic on governance: The case of México. GSC Biological and Pharmaceutical Sciences, 2022, 20(3), 167-174. Article DOI: https://doi.org/10.30574/gscbps.2022.20.3.0358